Journal of Advanced Research《前沿研究杂志》(可网站投稿)

Journal of Advanced Research《前沿研究杂志》(双月刊). Journal of Advanced Research (abbreviated as J. Adv. Res.) is an applied/natural sciences, peer-reviewed journal with interdisciplinary activity. The journal aims to make significant contributions to applied research and knowledge across the globe through publication of original, high-quality research articles fields.

杂志简称:j adv res
中文译名:《前沿研究杂志》
收录属性:scie(2024版), 目次收录(知网),英文期刊,
自引率:1.40%
投稿方向:综合性期刊、multidisciplinary sciences综合性期刊

Journal of Advanced Research《前沿研究杂志》

SCI/E期刊基本信息

出版周期:双月刊 地区:美国
中科院分区:2区
是否TOP:非TOP期刊
是否综述:非综述期刊
是否OA:OA期刊
国际标准刊号:ISSN 2090-1232;EISSN 2090-1224
杂志语言:英语
出版国家:美国

杂志官网 联系方式

出版地址:RADARWEG 29, AMSTERDAM, NETHERLANDS, 1043 NX
杂志邮箱:
投稿网址:https://www.editorialmanager.com/jare/default1.aspx
杂志官方网址:https://www.sciencedirect.com/journal/journal-of-advanced-research
出版商网址:http://www.elsevier.com

杂志投稿要求

投稿须知【杂志社官方网站信息】

Journal of Advanced Research

Guide for Authors

Editorial policy and general information

The Journal of Advanced Research (JAR) publishes original articles in the fields of the basic sciences, applied sciences and technology, biomedical sciences, and related disciplines. JAR seeks to publish high-quality papers that: 1) describe significant and novel findings; and 2) advanced knowledge in a diversity of scientific fields in the form of original articles, short communications, reviews, case reports, or letters to the editor.

Review process

Manuscripts are evaluated on the basis that they present new insight into the investigated topic and are likely to contribute to research progress or a change in clinical practice. It is understood that all authors listed on a manuscript have agreed to its submission. The signature of the corresponding author on the letter of submission signifies that these conditions have been fulfilled. Received manuscripts will initially be examined by the JAR editorial office and those deemed to have insufficient grounds for publication may be rejected without external evaluation. Manuscripts not prepared in the advised style described below will be sent back to authors for correction. The authors will be notified with the reference number once the manuscript has been assigned to an Editor. The assigned manuscripts will be sent to 2-4 independent experts for scientific evaluation. The evaluation process commonly takes an average of 1-3 months.Editors are not involved in decisions about papers which they have written themselves or have been written by family members or colleagues or which relate to products or services in which the editor has an interest. Any such submission is subject to all of the journal's usual procedures, with peer review handled independently of the relevant editor and their research groups.

Permissions

Authors wishing to include figures, tables, or text that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any received material lacking such evidence will be assumed to originate from the authors.

Disclaimer

Every effort is made by the publisher and editorial board to ensure that no inaccurate or misleading data or statements appear in the Journal of Advanced Research. However, they wish to make it clear that the data and opinions appearing in the articles herein are the responsibility of the authors concerned. Accordingly, the publisher and the editorial board accept no liability whatsoever for the consequences of any inaccurate or misleading data or statements, intentional or not.

Articles types

JAR seeks to publish experimental and theoretical research results of outstanding significance in the form of original articles, short communications and reviews.

Original articles: Articles which represent in-depth research in various scientific disciplines.

Short communications: Should be complete manuscripts of significant importance. However, their length and/or depth do not justify a full-length paper. The total number of figures and tables should not exceed 6. The number of words should be = 3,000

Review articles: Should normally comprise less than 10,000 words; contain structured abstract and includes up-to-date references. Meta-analyses are considered as reviews. Special attention will be paid to the teaching value of review papers.

Mini reviews: These are reviews of important and recent topics that are presented in a concise and well-focused manner. The number of words is limited to 5,000 words.

Special reports: Papers may be accepted on the basis that they provide a systematic, critical and up-to-date overview of literature pertaining to research or clinical topics.

Ethics in publishing

Please see our information on Ethics in publishing.

Ethical approval

Studies on patients or volunteers require Ethics Committee and/or Independent Review Board (IRB) approval, and, where relevant, the patients' written informed consent, which should be documented in the Methods section of the paper with the approval number. If such a study was not approved by the appropriate Ethics Committee or IRB, a statement as to why it was exempted should be included. The Editors reserve the right to refuse publications where the required ethical approval/patient consent is lacking.

Studies in humans and animals

If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.

刊知网 精心整理,转载请注明出处:https://www.kanzhiwang.com/archives/32235

我要点评 请您把投稿经验分享出来 让大家少走弯路少踩坑,我为人人、人人为我。

内容纠错 您如果发现杂志信息有错漏 可以在下方留言。

上一篇 2024年11月8日 下午1:40
下一篇 2024年11月8日 下午1:41

相关推荐

发表回复

登录后才能评论

联系我们

191 1833 1195

在线咨询: QQ交谈

邮件:321628655@qq.com

工作时间:周一至周五,9:30-18:30,节假日休息